[1]邓诗航,张益生,代丹,等.基于网络药理学的开通玄府法与清热凉血法治疗银屑病药效机制对比研究[J].国际中医中药杂志,2022,44(08):917-924.[doi:10.3760/cma.j.cn115398-20220104-00021]
 Deng Shihang,Zhang Yisheng,Dai Dan,et al.A comparative study of the mechanisms of Opening Xuanfu therapy and Qingre Liangxue therapy in the treatment of psoriasis based on network pharmacology[J].Int J Trad Chin Med,2022,44(08):917-924.[doi:10.3760/cma.j.cn115398-20220104-00021]
点击复制

基于网络药理学的开通玄府法与清热凉血法治疗银屑病药效机制对比研究

参考文献/References:

[1] 中华医学会皮肤性病学分会银屑病专业委员会. 中国银屑病诊疗指南(2018完整版)[J]. 中华皮肤科杂志,2019,52(10):667-710. DOI:10.35541/cjd.20190847.
[2] Yeung H,Takeshita J,Mehta NN, et al. Psoriasis severity and the prevalence of major medical comorbidity: a population-based study[J]. JAMA Dermatol,2013,149(10):1173-1179. DOI:10.1001/jamadermatol.2013.5015.
[3] 中华中医药学会皮肤科分会,北京中医药学会皮肤病专业委员会,北京中西医结合学会皮肤性病专业委员会. 寻常型银屑病(白疕)中医药循证临床实践指南(2013版)[J]. 中医杂志,2014,55(1):76-82.DOI:10.13288/j.11-2166/r.2014.01.021.
[4] 宋坪,杨柳,吴志奎,等. 从玄府理论新视角论治银屑病[J]. 北京中医药大学学报,2009,32(2):136-138 DOI:10.3321/j.issn:1006-2157.2009.02.018.
[5] 刘爱民. 运用温法、散法治疗寻常型银屑病体会[J]. 中医杂志,2009,50(9):792-793. DOI:10.13288/j.11-2166/r.2009.09.007.
[6] 姚菁华. 开通玄府、通络解毒法治疗斑块状银屑病临床研究[J]. 现代医学与健康研究电子杂志,2018,2(20):176-177.
[7] 宋坪,王晓旭,杨茂誉,等. 开通玄府、通络解毒法治疗斑块状银屑病120例疗效观察[J]. 中医杂志,2013,54(17):1476-1479. DOI:10.13288/j.11-2166/r.2013.17.013.
[8] 刘爱民,崔利莎,张步鑫,等. 麻防犀角地黄汤与犀角地黄汤治疗冬季血热型银屑病的疗效观察[J]. 中国皮肤性病学杂志,2016,30(6):629-630. DOI:10.13735/j.cjdv.1001-7089.201510007.
[9] 刘爱民,吴盘红,张步鑫,等. 中医辨治新体系对寻常型银屑病患者血清IL-17A、IL-23表达的影响研究[J]. 时珍国医国药,2020,31(4):886-887. DOI:10.3969/j.issn.1008-0805.2020.04.034.
[10] Liu A,Zhao W,Zhang B,et al. Cimifugin ameliorates imiquimod-induced psoriasis by inhibiting oxidative stress and inflammation via NF-κB/MAPK pathway[J]. Biosci Rep,2020,40(6):BSR20200471. DOI:10.1042/BSR20200471.
[11] 柴倩云,尹秀平,朱榕嘉,等. 从间充质干细胞调控免疫平衡作用探讨中医扶正祛邪治疗银屑病[J]. 中医杂志,2019,60(3):206-209. DOI:10.13288/j.11-2166/r.2019.03.007.
[12] 代丹. 基于代谢组学探讨"开玄解毒、补肾培元"法对银屑病脂代谢影响[D]. 北京:北京中医药大学,2021.
[13] 中华中医药学会皮肤科分会. 皮肤科分会银屑病中医治疗专家共识(2017年版)[J]. 中国中西医结合皮肤性病学杂志,2018,17(3):273-277. DOI:10.3969/j.issn.1672-0709.2018.03.028.
[14] Ru J,Li P,Wang J,et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines[J]. J Cheminform,2014,6:13. DOI:10.1186/1758-2946-6-13.
[15] Xu HY,Zhang YQ,Liu ZM,et al. ETCM: an encyclopaedia of traditional Chinese medicine[J]. Nucleic Acids Res,2019, 47(D1):D976-D982. DOI:10.1093/nar/gky987.
[16] Huang L,D Xie,Yu Y,et al. TCMID 2.0: a comprehensive resource for TCM[J]. Nucleic Acids Research,2018(D1):D1117-D1120. DOI:10.1093/nar/gkx1028.
[17] Xu X,Zhang W,Huang C,et al. A novel chemometric method for the prediction of human oral bioavailability[J]. Int J Mol Sci,2012,13(6):6964-6982. DOI:10.3390/ijms13066964.
[18] Yang H,Zhang W,Huang C,et al. A novel systems pharmacology model for herbal medicine injection: a case using Reduning injection[J]. BMC Complement Altern Med,2014,14:430. DOI:10.1186/1472-6882-14-430.
[19] 罗静初. UniProt蛋白质数据库简介[J]. 生物信息学,2019,17(3):131-144. DOI:10.12113/j.issn.1672-5565.201903005.
[20] 蒿花,田国祥,耿辉,等. 人类基因综合分析数据库GeneCards的应用介绍[J]. 中国循证心血管医学杂志,2021,13(8):902-906. DOI:10.3969/j.issn.1674-4055.2021.08.03.
[21] Amberger JS,Hamosh A. Searching Online Mendelian Inheritance in Man (OMIM): A Knowledgebase of Human Genes and Genetic Phenotypes[J]. Curr Protoc Bioinformatics,2017,58:1.2.1-1.2.12. DOI:10.1002/cpbi.27.
[22] Chin CH,Chen SH,Wu HH,et al. cytoHubba: identifying hub objects and sub-networks from complex interactome[J]. BMC Syst Biol,2014,8 Suppl 4(Suppl 4):S11. DOI:10.1186/1752-0509-8-S4-S11.
[23] Zhou Y,Zhou B,Pache L,et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets[J]. Nat Commun,2019,10(1):1523. DOI:10.1038/s41467-019-09234-6.
[24] 周冬梅,赵炳南. 从血论治银屑病探源[N]. 中国中医药报,2015-01-23(004).
[25] 吕景晶. 张志礼教授治疗银屑病的经验[C]//中国中西医结合学会皮肤性病专业委员会. 2019全国中西医结合皮肤性病学术年会论文汇编,江阴,2019:214.
[26] 张晓红,颜志芳. 庄国康教授运用活血法治疗斑块型银屑病经验[J]. 中华中医药杂志,2015,30(10):3573-3575.
[27] 刘完素. 素问玄机原病式[M]. 丁侃,校注. 北京:人民卫生出版社,1997:11.
[28] 张雅雯,冯瑞雪,张紫微,等. 从开通玄府谈对麻黄功效的新认识[J]. 江西中医药,2021,52(10):24-27.
[29] 刘克林. 王明杰教授开通玄府学术思想与用药经验[J]. 四川中医,2007,25(11):6-8.
[30] Vasilopoulos Y,Sourli F,Zafiriou E,et al.High serum levels of HIF-1αin psoriatic patients correlate with an over-expression of IL-6[J].Cytokine,2013,62(1):38-39. DOI: 10.1159/000103385.
[31] 倪晓,孙建方,曾学思,等. c-myc、p53和bcl-2与银屑病角质形成细胞凋亡异常关系的研究[J]. 中华皮肤科杂志, 2000,33(4):26-28. DOI:10.3760/j.issn:0412-4030.2000.04.008.
[32] 刘厚君,吴艳,林能兴,等. 寻常型银屑病皮损中细胞周期蛋白A、D1、B1和E的表达[J]. 中国麻风皮肤病杂志,2007,23(2):98-100. DOI:10.3969/j.issn.1009-1157.2007.02.002.
[33] Zhang GL,Zou YF,Feng XL,et al. Association of the NFKBIA gene polymorphisms with susceptibility to autoimmune and inflammatory diseases: a meta-analysis[J]. Inflamm Res,2011,60(1):11-18. DOI:10.1007/s00011-010-0216-2.
[34] 夏萍,周小勇. 银屑病角质形成细胞核因子κB抑制剂α的表达研究[J]. 世界临床药物,2019,40(11):771-775,794. DOI:10.13683/j.wph.2019.11.005.
[35] 高奎斌,李萍,王雅坤,等. 寻常型银屑病患者皮损中Caspase-3和bcl-xL 的表达[J]. 中华皮肤科杂志,2004,37(10):587-588. DOI:10.3760/j.issn:0412-4030.2004.10.009.
[36] 张念念,吴艳,刘贞富,等. HtrA2/Omi、XIAP和Caspase-3在银屑病皮损中的表达[J].中国麻风皮肤病杂志,2012,28(3):155-157. DOI:10.3969/j.issn.1009-1157.2012.03.002.
[37] 王雯竹,何艳艳,徐浩翔. EGFR通路在相关皮肤病发病机制中的研究进展[J]. 中国麻风皮肤病杂志,2020,36(11):697-700. DOI:10.12144/zgmfskin202011697.
[38] Jiang M,Li B,Zhang J,et al. Vascular endothelial growth factor driving aberrant keratin expression pattern contributes to the pathogenesis of psoriasis[J]. Exp Cell Res,2017,360(2):310-319. DOI:10.1016/j.yexcr.2017.09.021.
[39] Benhadou F,Glitzner E,Brisebarre A,et al. Epidermal autonomous VEGFA/Flt1/Nrp1 functions mediate psoriasis-like disease[J]. Sci Adv,2020,6(2):eaax5849. DOI: 10.1126/sciadv.aax5849.
[40] 王烁. 寻常型银屑病代谢相关特征的临床及血清代谢组学初探[D]. 北京:北京中医药大学,2019.
[41] Mease PJ,McInnes IB,Kirkham B,et al. Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis[J]. N Engl J Med,2015,373(14):1329-1339. DOI:10.1056/NEJMoa1412679.
[42] Hagag MM,Ghazy MM,Elhelbawy NG. Tumor necrosis factor-α gene promoter -308 and -238 polymorphisms and its serum level in psoriasis[J]. Biochem Biophys Rep,2021,27:101050. DOI:10.1016/j.bbrep.2021.101050.
[43] Fei X,Zhang X,Wang Q,et al. Xijiao Dihuang Decoction Alleviates Ischemic Brain Injury in MCAO Rats by Regulating Inflammation, Neurogenesis, and Angiogenesis[J]. Evid Based Complement Alternat Med,2018:1-12. DOI:10.1155/2018/5945128.

备注/Memo

基金项目:国家自然科学基金项目(82074448);中国中医科学院科技创新工程项目(461035)

更新日期/Last Update:

2022-08-17